Aug 2026· Measurement Science Review· Vol 26, pp. 219 - 223· 0 citations· 19 references
TL;DR
This review summarizes current knowledge on neuroimaging data harmonization, inter-scanner variability, radiomic feature repeatability, standardized QA procedures, and the challenges associated with integrating artificial intelligence into clinical workflows to highlight the need for unified methodologies, transparent protocols, and robust validation frameworks for reliable clinical translatability of MRI.
Abstract
Abstract Magnetic resonance imaging (MRI) is one of the most important imaging modalities in clinical diagnostics and biomedical research; however, its usability is significantly limited by the high technical and methodological variability across sites, scanners, and acquisition protocols. This lack of uniformity affects quantitative measurements, reduces their reproducibility, and complicates multicenter studies. In recent years, numerous initiatives and technical approaches have emerged, focusing on acquisition standardization, data harmonization, signal quality assessment, and validation of quantitative methods. This review summarizes current knowledge on neuroimaging data harmonization (e.g., ComBat), inter-scanner variability, radiomic feature repeatability, standardized QA procedures, and the challenges associated with integrating artificial intelligence into clinical workflows. Metrological frameworks such as the Quantitative Imaging Biomarker Alliance (QIBA) further emphasize the need for clearly defined measurands, reference methods, and reproducible acquisition conditions. Special attention is given to large dataset initiatives, preclinical standardization platforms, and open tools for MRI quality assessment. The review highlights the need for unified methodologies, transparent protocols, and robust validation frameworks that are essential for the reliable clinical translatability of MRI.
Background: Magnetic Resonance Imaging (MRI) has traditionally been regarded as a qualitative imaging modality that primarily relies on signal intensity differences for tissue characterization. While conventional MRI provides excellent anatomical detail, it frequently fails to detect subtle biochemical and microstructural alterations preceding macroscopic structural abnormalities. Quantitative MRI (qMRI) has emerged as a transformative imaging approach by providing objective, reproducible, and numerical biomarkers that reflect tissue composition, architecture, and physiology. Unlike conventional qualitative assessment, qMRI enables standardized evaluation of disease progression, treatment response, and tissue repair, thereby facilitating precision medicine. Objective: This review summarizes recent advances in quantitative MRI biomarkers with emphasis on their applications in musculoskeletal and neuroimaging. The review critically evaluates current techniques, discusses their biological significance, compares their diagnostic performance, and highlights future directions involving artificial intelligence and multiparametric imaging. Methods: Recent literature published between 2021 and 2026 was reviewed to identify clinically relevant quantitative MRI techniques and their applications. Major databases including PubMed, Scopus, Web of Science, and Google Scholar were surveyed. Quantitative imaging biomarkers including T1 mapping, T2 mapping, T2* mapping, diffusion-weighted imaging (DWI), diffusion tensor imaging (DTI), intravoxel incoherent motion (IVIM), magnetization transfer imaging (MTI), MR fingerprinting (MRF), chemical exchange saturation transfer (CEST), quantitative susceptibility mapping (QSM), and synthetic MRI were evaluated Results: Quantitative MRI has demonstrated substantial potential for detecting early biochemical alterations before irreversible structural damage becomes evident. In musculoskeletal imaging, quantitative biomarkers have enabled early diagnosis of cartilage degeneration, tendon injury, muscle pathology, intervertebral disc degeneration, and bone marrow disorders. In neuroimaging, quantitative MRI has significantly improved characterization of neurodegenerative diseases, multiple sclerosis, stroke, epilepsy, traumatic brain injury, and brain tumors by providing objective measures of tissue microstructure, myelin integrity, iron deposition, and cellularity. Emerging developments integrating artificial intelligence, radiomics, deep learning, and multiparametric MRI have further enhanced diagnostic accuracy and prognostic prediction. Conclusion: Quantitative MRI represents a paradigm shift from subjective image interpretation toward objective imaging biomarkers. Despite ongoing challenges related to standardization, acquisition time, multicenter reproducibility, and clinical implementation, quantitative MRI is expected to become an integral component of routine musculoskeletal and neuroimaging practice. Future research focusing on harmonized acquisition protocols, AI-assisted analysis, and large multicenter validation studies will accelerate the translation of quantitative MRI biomarkers into personalized clinical care.
Shubhanshi Rani, Dr. Vijay Kishor Chakravarti, Anjali Raghav et al.· Genetics and Molecular Resea...· 0 citations
Brain volume change over time is an important imaging-based biomarker of disease. However, traditional MR scanners are associated with high direct and indirect costs both up front and over time, rendering them inaccessible to many around the world. Recently, ultra-low-field (64 mT) portable MR scanners have been introduced for clinical use and have been highly safe and informative for neurologic monitoring. Volumetrics present an important potential use for ultra-low-field MRI that has yet to be established. The aim of the present work was to examine qualitative similarities between volume measurements in adults and to address the questions of reproducibility through test-retest reliability and external validity using recent software updates to the Hyperfine Swoop system, versions 8.8.1 and 9.0.0. In twenty neurologically typical adults, structural volumes demonstrated high test-retest intraclass correlations regardless of software (>0.999-0.883). Regional intraclass correlations also were explored, with the lowest stability observed in structures that were relatively central and caudal, though more recent software provided relative improvements. Regardless of field strength or software, measurements were comparable to those established in growth charts. These findings constitute a crucial foundation for the clinical utility of 64 mT MRI in monitoring brain volume loss over time.
M. Stockbridge, Rex Wang, V. Neal et al.· Aperture Neuro· 0 citations
Multi-site data collection enables the aggregation of large and diverse magnetic resonance imaging (MRI) datasets, which are essential for development of robust machine learning (ML) models in neuroimaging. However, site-related variability introduced by differences in scanner equipment and acquisition protocols (i.e. "batch effects") may confound downstream analyses and obscure meaningful information. Harmonization methods, aim to eliminate this site-induced variability from the data while preserving true biological signals through covariates integrated into the harmonization models. Beside harmonization, MRI quality control is also an essential step in data preparation. However, for multi-site data, image quality metrics (IQMs) designed to capture quality-related properties of the recordings, may also contain site-specific characteristics. Although harmonization methods such as ComBat, are widely used to mitigate batch effects, their impact on IQMs and the role of incorporated covariates remain insufficiently understood. To address these shortcomings, in this study, we evaluate the effects of different batch correction strategies on structural brain MRI IQMs by comparing simple data merging, database-wise standardization, ComBat without and with age and sex included as biological covariates through downstream application of ML models, and by statistical comparison of feature values for validation. We show that both database-wise scaling and harmonization reduce site-related information, however, nonlinear batch effects remain in the data. We also demonstrate that biological information is attenuated if not incorporated into the model as covariates, which in turn reduces harmonization effectiveness. Furthermore, we identify and analyze the most influential IQMs for site, age, and sex prediction across the different data processing strategies.
Vilmos Madaras, Z. Vidnyánszky, Béla Weiss· International Conference on...· 0 citations